Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Daiichi Sankyo
US Department of Justice
Queensland Health
Federal Trade Commission
Argus Health
Cipla
Fuji

Generated: April 24, 2018

DrugPatentWatch Database Preview

METUBINE IODIDE Drug Profile

« Back to Dashboard

When do Metubine Iodide patents expire, and when can generic versions of Metubine Iodide launch?

Metubine Iodide is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in METUBINE IODIDE is metocurine iodide. There is one drug master file entry for this compound. Additional details are available on the metocurine iodide profile page.
Drug patent expirations by year for METUBINE IODIDE
Synonyms for METUBINE IODIDE
(+)-O,O'-Dimethylchondrocurarine Di-iodide
(+)-O,O'-Dimethylchondrocurarine diiodide
(1S,16R)-9,10,21,25-TETRAMETHOXY-15,15,30,30-TETRAMETHYL-7,23-DIOXA-15,30-DIAZAHEPTACYCLO[22.6.2.2(3),?.1?,(1)(2).1(1)?,(2)(2).0(2)?,(3)(1).0(1)?,(3)?]HEXATRIACONTA-3,5,8,10,12(34),18,20,22(33),24(32),25,27(31),35-DODECAENE-1
13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, diiodide, (13aR-(13aR*,25aS*))-
13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, diiodide, (13aR,25aS)-
2,2,2',2'-tetramethyl-6,6',7',12'-tetrakis(methyloxy)tubocuraran-2,2'-diium diiodide
5152-30-7 (Parent)
6,6',7',12'-Tetramethoxy-2,2,2',2'-tetramethyltubocuraranium diiodide
7601-55-0
AC1L2NB6
AC1Q1T8M
C-23574
C40H48N2O6
CAS-7601-55-0
CHEBI:6901
CHEMBL1739
D00761
D0Y6CE
DB00416
Dimethyl tubocurarine iodide
Dimethylchondrocurarine iodide
Dimethylether of d-tubocurarine iodide
Dimethyltubocurarine Iodide
Dimethyltubocurarinium iodide
Dimetiltubocurarinio, ioduro de
DR003629
DSSTox_CID_2944
DSSTox_GSID_22944
DSSTox_RID_76799
DTXSID9022944
EINECS 231-510-3
LS-158180
Methyl-curarin
Methyl-curarin [German]
metocurine diiodide
METOCURINE IODIDE
Metocurine iodide (USAN)
Metocurine iodide [USAN]
Metocurini Iodidum
Metokuriinijodidi
Metokurinjodid
Metubine
Metubine iodide (TN)
Mutubine Iodide
NCGC00181151-01
NCGC00263444-01
NSC 36388
O,O'-Dimethylchondrocurarine diiodide
O0U0E87X7F
SCHEMBL415745
Tetrandrini dimethiodidum
Tox21_112755
Tox21_112755_1
Trimethyltubocurarine Iodide
Tubocuraranium, 6,6',7',12'-tetramethoxy-2,2,2',2'-tetramethyl-, diiodide
Tubocurarine, O,O'-dimethyl-, diiodide
UNII-O0U0E87X7F

US Patents and Regulatory Information for METUBINE IODIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly METUBINE IODIDE metocurine iodide INJECTABLE;INJECTION 006632-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Baxter
Deloitte
Cipla
Accenture
Citi
Daiichi Sankyo
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.